Multifocal osteoarthritis due to Candida albicans in a neonate: Serum level monitoring of liposomal amphotericin B and literature review

Infection

Volumn 25, Issue 2, 1997, Pages 112-116

  Evdoridou, J ^a   Roilides, E ^a   Bibashi, E ^a   Kremenopoulos, G ^a  

^a ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B DEOXYCHOLATE; AMPHOTERICIN B LIPID COMPLEX; ANTIFUNGAL AGENT; FLUCYTOSINE;

ARTICLE; CANDIDA ALBICANS; CANDIDIASIS; CASE REPORT; DRUG BLOOD LEVEL; DRUG MONITORING; DRUG SYNOVIAL FLUID LEVEL; FUNGEMIA; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; NEWBORN; NEWBORN DISEASE; OSTEOARTHRITIS;

AMPHOTERICIN B; ANTIBIOTICS, ANTIFUNGAL; ANTIFUNGAL AGENTS; BONE AND BONES; CANDIDIASIS; DRUG CARRIERS; DRUG THERAPY, COMBINATION; FLUCYTOSINE; HUMANS; INFANT; INFANT, NEWBORN; LIPOSOMES; MALE; MICROBIAL SENSITIVITY TESTS; OSTEOARTHRITIS;

EID: 0030959488     PISSN: 03008126     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02113589     Document Type: Article

References (29)

1. Feigin, R. D., Adcock, L. M., Edwards, M. S.: Fungal and protozoal infections. In: Fanaroff, A. A., Martin, R. J. (eds.): Neonatal-perinatal medicine - diseases of the fetus and infant. Mosby-Year Book Inc, St Louis 1992, pp. 683-690.
2. Anderson, D. C., Pickering, L. K., Feigin, R. D.: Leukocyte function in normal and infected neonates. J. Pediatr. 85 (1974) 420-425.
3. Shigeoka, A. O., Charette, R. P., Wyman, M. L., Hill, H. R.: Defective oxidative metabolic responses of neutrophils from stressed neonates. J. Pediatr. 98 (1981) 392-398.
4. Cairo, M. S.: Neonatal neutrophil host defense. Prospects for immunologic enhancement during neonatal sepsis. Am. J. Dis. Child 143 (1989) 40-46.
5. Faix, R. G.: Invasive neonatal candidiasis: comparison of albicans and parapsilosis infection. Pediatr. Infect. Dis. J. 11 (1992) 88-93.
6. Butler, K. M., Baker, C. J.: Candida: an increasingly important pathogen in the nursery. Pediatr. Clin. North Am. 35 (1988) 543-563.
7. Wong, M., Isaacs, D., Howman-Gils, R., Uren, R.: Clinical and diagnostic features of osteomyelitis occurring in the first 3 months of life. Pediatr. Infect. Dis. J. 14 (1995) 1047-1053.
8. Svirsky-Fein, S., Langer, L., Milbauer, B., Khermosh, O., Rubinstein, E.: Neonatal osteomyelitis caused by Candida tropicalis. Report of two cases and review of the literature. J. Bone Joint Surg. 61 (1979) 455-459.
9. Oleinik, E. M., Della-Latta, P., Rinaldi, M. G., Seiman, L.: Candida lusitaniae osteomyelitis in a premature infant. Am. J. Perinatol. 10 (1993) 313-315.
10. Ward, R. M., Sattler, F. R., Dalton, A. S.: Assessment of antifungal therapy in an 800-gram infant with candidal arthritis and osteomyelitis. Pediatrics 72 (1983) 234-238.
11. Gathe, J. C., Harris, R. L., Garland, B., Bradshaw, M. W., Williams, T. W.: Candida osteomyelitis. Report of five cases and review of the literature. Am. J. Med. 82 (1987) 927-937.
12. National Committee for Clinical Laboratory Standards: Reference method for broth dilution antifungal susceptibility testing of yeasts: proposed standard. NCCLS document M27-P (ISBN 1-56238-186-5). NCCLS, Villanova, PA 1992.
13. Pruitt, A. W., Achord, J. L., Fales, F. W., Patterson, J. H.: Glucose-galactose malabsorption complicated by monilial arthritis. Pediatrics 43 (1969) 106-110.
14. Adler, S., Randall, J., Plotkin, S. A.: Candidal osteomyelitis and arthritis in a neonate. Am. J. Dis. Child 123 (1972) 595-596.
15. Freeman, J. B., Wienke, J. W., Soper, R. T.: Candida osteomyelitis associated with intravenous alimentation. J. Pediatr. Surg. 9 (1974) 783-784.
16. Pittard, W. B., Thullen, J. D., Fanaroff, A. A.: Neonatal septic arthritis. J. Pediatr. 88 (1976) 621-624.
17. Omene, J. A., Odita, J. C., Okolo, A. A.: Neonatal osteomyelitis in Nigerian infants. Pediatr. Radiol. 14 (1984) 318-322.
18. Pope, T. L.: Pediatric Candida albicans arthritis: case report of hip involvement with a review of the literature. Prog. Pediatr. Surg. 15 (1982) 271-283.
19. Beck-Sague, C. M., Jarvis, W. R., the National Nosocomial Infections Surveillance System: Secular trends in the epidemiology of nosocomial fungal infections in the United States. 1980-1990. J. Infect. Dis. 167 (1993) 1247-1251.
20. Dan, M.: Septic arthritis in young infants: clinical and microbiologic correlations and therapeutic implications. Rev. Infect. Dis. 6 (1984) 147-155.
21. Weese-Mayer, D. E., Wheeler Fondriest, D., Brouillette, R. T., Shulman, S. T.: Risk factors associated with candidemia in the neonatal intensive care unit: a case-control study. Pediatr. Infect. Dis. J. 6 (1987) 190-196.
22. Van den Anker, J. N., van Popele, N. M. L., Sauer, P. J. J.: Antifungal agents in neonatal systemic candidiasis. Antimicrob. Agents Chemother. 39 (1995) 1391-1397.
23. Farrell, J. B., Person, D. A., Lidsky, M. D., Hopfer, R. L., Musher, D. M.: Candida tropicalis arthritis-assessment of amphotericin B therapy. J. Rheumatol. 5 (1978) 267-271.
24. Weisse, M. E., Person, D. A., Berkenbaugh, J. T.: Treatment of Candida arthritis with flucytosine and amphotericin B. J. Perinatol. 13 (1993) 402-404.
25. Lopez-Berestein, G., Bodey, G. P., Fainstein, V., Keating, M., Frankel, L., Zeluff, B., Gentry, L., Mehta, K.: Treatment of systemic fungal infections with liposomal amphotericin B. Arch. Intern. Med. 149 (1989) 2533-2536.
26. Vincent, M., Webster, M. H., Pether, J. V. S.: Liposomal amphotericin B. Lancet 339 (1992) 374-375.
27. Lackner, H., Schiwinger, W., Urban, C., Muller, W., Ritschl, E., Reiterer, F., Kuttnig-Haim, M., Urlesberger, B., Hauer, C.: Liposomal amphotericin-B (AmBisome) for treatment of disseminated fungal infections in two infants of very low birth weight. Pediatrics 89 (1992) 1259-1261.
28. daSilva, L. P., Amaral, J. M. V., Ferreira, N. C.: Which is the most appropriate dosage of liposomal amphotericin B (AmBisome) for the treatment of fungal infections in infants of very low birth weight? Pediatrics 91 (1993) 1217-1218.
29. Bennett, J. E.: Antifungal agents. In: Mandell, G. L., Bennett, J. E., Dolin, R. (eds.): Principles and practice of infectious diseases. Churchill Livingstone, New York 1995, pp. 401-410.